Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

165 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Comparison of nodal staging between CT, MRI, and [18F]-FDG PET/MRI in patients with newly diagnosed breast cancer.
Morawitz J, Bruckmann NM, Dietzel F, Ullrich T, Bittner AK, Hoffmann O, Ruckhäberle E, Mohrmann S, Häberle L, Ingenwerth M, Abrar DB, Sawicki LM, Breuckmann K, Fendler WP, Herrmann K, Buchbender C, Antoch G, Umutlu L, Kirchner J. Morawitz J, et al. Among authors: haberle l. Eur J Nucl Med Mol Imaging. 2022 Feb;49(3):992-1001. doi: 10.1007/s00259-021-05502-0. Epub 2021 Sep 3. Eur J Nucl Med Mol Imaging. 2022. PMID: 34476552 Free PMC article.
Prospective Correlation of Prognostic Immunohistochemical Markers With SUV and ADC Derived From Dedicated Hybrid Breast 18F-FDG PET/MRI in Women With Newly Diagnosed Breast Cancer.
Morawitz J, Kirchner J, Martin O, Bruckmann NM, Dietzel F, Li Y, Rischpler C, Herrmann K, Umutlu L, Bittner AK, Mohrmann S, Ingenwerth M, Häberle L, Esposito I, Antoch G, Buchbender C, Sawicki LM. Morawitz J, et al. Among authors: haberle l. Clin Nucl Med. 2021 Mar 1;46(3):201-205. doi: 10.1097/RLU.0000000000003488. Clin Nucl Med. 2021. PMID: 33351505
Is there a diagnostic benefit of late-phase abdomino-pelvic PET/CT after urination as part of whole-body 68 Ga-PSMA-11 PET/CT for restaging patients with biochemical recurrence of prostate cancer after radical prostatectomy?
Morawitz J, Kirchner J, Hertelendy J, Loberg C, Schimmöller L, Dabir M, Häberle L, Mamlins E, Antke C, Arsov C, Antoch G, Sawicki LM. Morawitz J, et al. Among authors: haberle l. EJNMMI Res. 2022 Mar 4;12(1):12. doi: 10.1186/s13550-022-00885-z. EJNMMI Res. 2022. PMID: 35244791 Free PMC article.
Multiparametric 18F-FDG PET/MRI-Based Radiomics for Prediction of Pathological Complete Response to Neoadjuvant Chemotherapy in Breast Cancer.
Umutlu L, Kirchner J, Bruckmann NM, Morawitz J, Antoch G, Ting S, Bittner AK, Hoffmann O, Häberle L, Ruckhäberle E, Catalano OA, Chodyla M, Grueneisen J, Quick HH, Fendler WP, Rischpler C, Herrmann K, Gibbs P, Pinker K. Umutlu L, et al. Among authors: haberle l. Cancers (Basel). 2022 Mar 29;14(7):1727. doi: 10.3390/cancers14071727. Cancers (Basel). 2022. PMID: 35406499 Free PMC article.
Clinical Decision Support for Axillary Lymph Node Staging in Newly Diagnosed Breast Cancer Patients Based on 18F-FDG PET/MRI and Machine Learning.
Morawitz J, Sigl B, Rubbert C, Bruckmann NM, Dietzel F, Häberle LJ, Ting S, Mohrmann S, Ruckhäberle E, Bittner AK, Hoffmann O, Baltzer P, Kapetas P, Helbich T, Clauser P, Fendler WP, Rischpler C, Herrmann K, Schaarschmidt BM, Stang A, Umutlu L, Antoch G, Caspers J, Kirchner J. Morawitz J, et al. Among authors: haberle lj. J Nucl Med. 2023 Feb;64(2):304-311. doi: 10.2967/jnumed.122.264138. Epub 2022 Sep 22. J Nucl Med. 2023. PMID: 36137756 Free PMC article.
Conventional Imaging, MRI and 18F-FDG PET/MRI for N and M Staging in Patients with Newly Diagnosed Breast Cancer.
Morawitz J, Bruckmann NM, Jannusch K, Dietzel F, Milosevic A, Bittner AK, Hoffmann O, Mohrmann S, Ruckhäberle E, Häberle L, Fendler WP, Herrmann K, Giesel FL, Antoch G, Umutlu L, Kowall B, Stang A, Kirchner J. Morawitz J, et al. Among authors: haberle l. Cancers (Basel). 2023 Jul 17;15(14):3646. doi: 10.3390/cancers15143646. Cancers (Basel). 2023. PMID: 37509307 Free PMC article.
Impact of 18F-FDG PET/MRI on Therapeutic Management of Women with Newly Diagnosed Breast Cancer: Results from a Prospective Double-Center Trial.
Jannusch K, Umutlu L, Kirchner J, Bruckmann NM, Morawitz J, Herrmann K, Fendler WP, Bittner AK, Hoffmann O, Mohrmann S, Ruckhäberle E, Stuschke M, Schmid W, Giesel F, Häberle L, Esposito I, Budach W, Grueneisen J, Matuschek C, Kowall B, Stang A, Antoch G, Buchbender C. Jannusch K, et al. Among authors: haberle l. J Nucl Med. 2024 Dec 3;65(12):1855-1861. doi: 10.2967/jnumed.124.268065. J Nucl Med. 2024. PMID: 39389629 Clinical Trial.
Ultra-sensitive CTC-based liquid biopsy for pancreatic cancer enabled by large blood volume analysis.
Stoecklein NH, Fluegen G, Guglielmi R, Neves RPL, Hackert T, Birgin E, Cieslik SA, Sudarsanam M, Driemel C, van Dalum G, Franken A, Niederacher D, Neubauer H, Fehm T, Rox JM, Böhme P, Häberle L, Göring W, Esposito I, Topp SA, Coumans FAW, Weitz J, Knoefel WT, Fischer JC, Bork U, Rahbari NN. Stoecklein NH, et al. Among authors: haberle l. Mol Cancer. 2023 Nov 13;22(1):181. doi: 10.1186/s12943-023-01880-1. Mol Cancer. 2023. PMID: 37957606 Free PMC article.
[Metastasis of pancreatic tumors].
Häberle L, Braren R, Schlitter AM, Esposito I. Häberle L, et al. Pathologe. 2015 Nov;36 Suppl 2:176-80. doi: 10.1007/s00292-015-0077-0. Pathologe. 2015. PMID: 26391249 Review. German.
165 results